Jubilee Life Insurance Company Limited (PSX:JLICL)
Pakistan · Delayed Price · Currency is PKR 170.00
-0.55 (-0.32%)
At close: Apr 30, 2026
PSX:JLICL Income Statement
Financials in millions PKR. Fiscal year is January - December.
Millions PKR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Premiums & Annuity Revenue | 58,327 | 56,655 | 46,563 | 44,086 | 45,571 | 47,580 |
Total Interest & Dividend Income | 23,364 | 24,472 | 35,279 | 30,714 | 19,080 | 12,275 |
Gain (Loss) on Sale of Investments | 7,173 | 15,395 | 18,321 | 2,774 | -14,737 | -8,309 |
Other Revenue | 344.79 | 346.53 | 629.75 | 616.34 | 333.68 | 216.75 |
| 89,209 | 96,869 | 100,792 | 78,190 | 50,248 | 51,762 | |
Revenue Growth (YoY) | -10.73% | -3.89% | 28.91% | 55.61% | -2.93% | -9.39% |
Policy Benefits | 70,170 | 78,085 | 82,766 | 61,716 | 35,833 | 38,306 |
Policy Acquisition & Underwriting Costs | 7,571 | 7,408 | 6,265 | 6,211 | 6,642 | 6,922 |
Selling, General & Administrative | 7,430 | 7,210 | 7,277 | 5,757 | 4,352 | 3,828 |
Other Operating Expenses | 32.37 | 31.38 | 31.69 | 42.36 | 44.22 | 61.41 |
Total Operating Expenses | 85,203 | 92,734 | 96,340 | 73,725 | 46,872 | 49,117 |
Operating Income | 4,006 | 4,135 | 4,452 | 4,465 | 3,377 | 2,646 |
Interest Expense | -97.16 | -106.24 | -203.33 | -191.43 | -130.92 | -144.98 |
Earnings From Equity Investments | 69.56 | 67.29 | 25.39 | 31.21 | 13.92 | 14.1 |
Currency Exchange Gain (Loss) | 0.09 | 0.09 | 17.55 | 12.46 | 13.96 | -8.81 |
Other Non Operating Income (Expenses) | 0.03 | 0.21 | 0.06 | - | - | - |
EBT Excluding Unusual Items | 3,978 | 4,096 | 4,292 | 4,317 | 3,274 | 2,506 |
Gain (Loss) on Sale of Assets | 85.73 | 85.73 | 33.2 | 35.91 | 27.37 | 34.4 |
Pretax Income | 4,064 | 4,182 | 4,325 | 4,353 | 3,301 | 2,540 |
Income Tax Expense | 1,651 | 1,686 | 1,751 | 2,047 | 1,229 | 747.13 |
Net Income | 2,413 | 2,496 | 2,574 | 2,306 | 2,072 | 1,793 |
Net Income to Common | 2,413 | 2,496 | 2,574 | 2,306 | 2,072 | 1,793 |
Net Income Growth | -0.22% | -3.04% | 11.60% | 11.30% | 15.56% | -37.83% |
Shares Outstanding (Basic) | 100 | 100 | 100 | 100 | 100 | 100 |
Shares Outstanding (Diluted) | 100 | 100 | 100 | 100 | 100 | 100 |
Shares Change (YoY) | -0.01% | - | 0.00% | - | -0.00% | - |
EPS (Basic) | 24.05 | 24.87 | 25.65 | 22.98 | 20.65 | 17.87 |
EPS (Diluted) | 24.05 | 24.87 | 25.65 | 22.98 | 20.65 | 17.87 |
EPS Growth | -0.22% | -3.04% | 11.60% | 11.30% | 15.56% | -37.83% |
Free Cash Flow | -10,039 | -11,426 | -22,619 | -13,815 | -6,644 | -1,962 |
Free Cash Flow Per Share | -100.05 | -113.86 | -225.39 | -137.66 | -66.21 | -19.55 |
Dividend Per Share | - | 13.000 | 13.000 | 13.000 | 11.304 | 12.609 |
Dividend Growth | - | - | - | 15.00% | -10.35% | -12.12% |
Operating Margin | 4.49% | 4.27% | 4.42% | 5.71% | 6.72% | 5.11% |
Profit Margin | 2.71% | 2.58% | 2.55% | 2.95% | 4.12% | 3.46% |
Free Cash Flow Margin | -11.25% | -11.79% | -22.44% | -17.67% | -13.22% | -3.79% |
EBITDA | 4,394 | 4,497 | 4,785 | 4,833 | 3,788 | 3,025 |
EBITDA Margin | 4.93% | 4.64% | 4.75% | 6.18% | 7.54% | 5.84% |
D&A For EBITDA | 388.14 | 362.24 | 332.9 | 367.77 | 411.4 | 379.48 |
EBIT | 4,006 | 4,135 | 4,452 | 4,465 | 3,377 | 2,646 |
EBIT Margin | 4.49% | 4.27% | 4.42% | 5.71% | 6.72% | 5.11% |
Effective Tax Rate | 40.63% | 40.33% | 40.49% | 47.02% | 37.23% | 29.41% |
Revenue as Reported | 89,295 | 96,955 | 100,843 | 78,239 | 50,290 | 51,788 |
Source: S&P Global Market Intelligence. Insurance template. Financial Sources.